Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-054993
Filing Date
2013-10-23
Accepted
2013-10-23 17:20:18
Documents
2
Period of Report
2013-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd393222.html 3  
1 FORM 3 rrd393222.xml 3 1545
2 POWER OF ATTORNEY rrd353761_400705.htm EX-24.1 3529
  Complete submission text file 0001181431-13-054993.txt   6400
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 190 WOOSAMONSA RD PENNINGTON NJ 08534
Business Address
Smaldone Alsup Laurie (Reporting) CIK: 0001589602 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35798 | Film No.: 131166334